AU Patent

AU2006329564A1 — Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative

Assigned to Pharmena North America Inc · Expires 2007-07-05 · 19y expired

What this patent protects

The present invention is directed to nicotinamide derivatives, and their use in treating lipoprotein abnormalities, alone or in combination with a statin.

USPTO Abstract

The present invention is directed to nicotinamide derivatives, and their use in treating lipoprotein abnormalities, alone or in combination with a statin.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006329564A1
Jurisdiction
AU
Classification
—
Expires
2007-07-05
Drug substance claim
No
Drug product claim
No
Assignee
Pharmena North America Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.